
The Most Advanced Conference to Modernize Clinical Research
The 15th Annual DPHARM® offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials.
DPHARM faculty challenge the clinical operations community to rethink how clinical research gets done to drive greater inclusivity and value for patients.
2025 First Keynotes Announced
R&D
Leadership

Ken Frazier, JD
Former CEO and Current Executive Chairman
Merck
Geopolitical
Impact on R&D

Scott Gottlieb, MD
23rd Commissioner of the FDA
Patient
Advocate

Victoria Gray
First CRISPR Gene Therapy
Recipient for SCD
State of Clinical Trial Operations
.png)
Kenneth Getz, MBA
Executive Director & Professor
Tufts CSDD, Tufts University School of Medicine
2025 Senior Clinical Operations Leadership

Jennifer Sheller, MPH
SVP, Head of Global Clinical Trial Operations, Global Clinical Development
Merck

Elspeth Carnan, PhD
VP, Head of Trial Delivery Support
BMS

David Carruthers
VP, Biopharma R&D Clinical Operations
AstraZeneca

Bernhard Glombitza, PhD
VP, Clinical Customer Engagement and Operations EMEA & LATAM
Bayer

Nikki Amaratunge
VP, Clinical Development Operations, Head of Clinical Site Management
AbbVie

Melika Davis
SVP, Global Head, Clinical Operations
BeiGene
AI Thought Leadership

Syed Wassim Haider, PhD
Head of Business, IT Partnership for AI
Merck

Youssef Idelcaid, MBA
Head of AI Research Center [ARC], Drug Development
Gilead Sciences

Faisal M Khan, PhD
Corporate Vice President, AI and Analytics
Novo Nordisk

Henry Wei, MD
Head of Development Innovation
Regeneron

Subha Madhavan, PhD
VP, Head of AI/ML, Quantitative and Digital Sciences R&D
Pfizer
Patient Disruptors

Yvonnne Florence
Patient Advocate

Patrick Gee Sr, PhD, JLC
Patient Advocate, Founder & Chief Executive Hope Dealer
iAdvocate, Inc

Sabina Kineen
Patient Advocate

Barry Nelson
Patient Advocate
 (1) (1).jpeg)
Rucha Shah
Patient Advocate and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group

Vivan Larsen
Associate Patient Recruitment & Retention Strategy Director,
Exelixis
Convening 1000+ Attendees
DPHARM 2024 featured senior clinical operation executives with industry and patient thought leadership, and technologists showcasing the latest innovations in clinical trials driving efficiencies in operational processes and reducing patient, site and physician obstacles to participating in research.


DPHARM Idol Disrupt
DPHARM Idol Disrupt is a series of quick-fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provides amazing shared learnings on how to properly assess new technologies.
Congratulations to 2024 Winner, Power!
If you are interested in applying for a spot as a DPHARM Idol Disrupt 2025 presenter, email Meredith@tcfllc.org
DPHARM Commitment
- DPHARM combines TED-style talks with fireside chats, quick fires, panels and demos presentations showcasing innovations from leading Pharma R&D practitioners and from other industries.
- DPHARM underscores the promise and challenge of innovation in advancing drug development.
- DPHARM features new models and collaborations to get therapeutics to patients faster.
- DPHARM features the full spectrum of clinical research options and utilizes insights more appropriately.
- DPHARM is dedicated to challenging creative solutions and finding a way to implement them.
